Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
发布时间：2025-11-23
点击次数：
- 发布时间：
- 2025-11-23
- 论文名称：
- Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
- 发表刊物：
- International Immunopharmacology
- ISSN号：
- 1567-5769
- 是否译文：
- 否
- 收录刊物：
- SCI
- 上一条：Four Main Active Ingredients Derived from a Traditional Chinese Medicine Guanxin Shutong Capsule Cause Cardioprotection during Myocardial Ischemia Injury Calcium Overload Suppression.
- 下一条：Clarithromycin-treated chronic spontaneous urticaria with the negative regulation of FcεRΙ and MRGPRX2 activation via CD300f